Literature DB >> 6314211

Effect of chronic ethanol treatment on adenylate cyclase activity in rat striatum.

L Lucchi, V Covelli, H Anthopoulou, P F Spano, M Trabucchi.   

Abstract

Chronic ethanol consumption induces an increase in striatal adenylate cyclase enzymatic activity but is unable to further potentiate the dopamine stimulated production of cyclic-AMP. In striatal membranes obtained from chronic ethanol-treated rats, apomorphine exerts a more potent inhibition of [3H]spiperone binding when compared with controls, demonstrating that ethanol increases the affinity of the dopaminergic receptors associated with adenylate cyclase activity. In addition, GTP is unable to modify the agonist component of dopamine receptor in membrane exposed 'in vivo' to ethanol. Data are discussed in terms of a derangement of receptor-adenylate cyclase coupling system produced by chronic ethanol treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6314211     DOI: 10.1016/0304-3940(83)90300-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Molecular mechanisms underlying striatal synaptic plasticity: relevance to chronic alcohol consumption and seeking.

Authors:  Kim T Blackwell; Armando G Salinas; Parul Tewatia; Brad English; Jeanette Hellgren Kotaleski; David M Lovinger
Journal:  Eur J Neurosci       Date:  2018-04-20       Impact factor: 3.386

2.  Genotypic differences in age and chronic alcohol exposure effects on somatostatin levels in hippocampus and striatum in mice.

Authors:  G Fuhrmann; M T Strosser; F Besnard; E Kempf; J Kempf; A Ebel
Journal:  Neurochem Res       Date:  1986-05       Impact factor: 3.996

3.  Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.

Authors:  Richard L Bell; Kelle M Franklin; Sheketha R Hauser; Feng C Zhou
Journal:  Recent Pat CNS Drug Discov       Date:  2012-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.